NCT02778750View on ClinicalTrials.gov

Evaluation Of The Pan-microbiome and Host Immune Response in CF

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

June 5, 2015

Primary Completion Date

June 16, 2017

Study Completion Date

March 12, 2020

Conditions
Cystic Fibrosis (CF)
Interventions
PROCEDURE

Two-Bronchoscope Technique

Used to validate the use of sputum to sample the lower airway microbiome

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02778750 - Evaluation Of The Pan-microbiome and Host Immune Response in CF | Biotech Hunter | Biotech Hunter